AMBITION: A Randomized, Multicenter Study of First-Line AMBrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension
The purpose of his study is to test how well the drugs ambrisentan and tadalafil work together to treat Pulmonary Arterial Hypertension (PAH) compared to ambrisentan or tadalafil alone. (Enrolling in Jacksonville, FL)
Keywordslung disease, pulmonary arterial hypertension
Principal InvestigatorAbubakr Bajwa, CLIN AST PROF-JAX
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.